StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2024 - 04 - 24
12
2024 - 03 - 04
14
2023 - 12 - 21
13
2023 - 12 - 12
13
2023 - 12 - 06
13
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
13
2023 - 06 - 26
13
2023 - 04 - 25
15
2023 - 04 - 17
14
2023 - 02 - 23
13
2023 - 01 - 30
16
2023 - 01 - 25
13
2022 - 10 - 12
13
2022 - 08 - 22
13
2022 - 06 - 06
11
2022 - 05 - 24
11
2022 - 05 - 17
13
2022 - 05 - 03
12
2022 - 05 - 02
11
2022 - 03 - 28
14
2022 - 01 - 24
18
2022 - 01 - 20
11
2022 - 01 - 18
11
2021 - 12 - 22
12
2021 - 12 - 21
11
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
13
2021 - 11 - 29
11
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
12
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
14
2021 - 04 - 14
11
2021 - 03 - 22
13
Sector
Health technology
8
Manufacturing
1
Process industries
2
Producer manufacturing
1
Tags
Acquisition
6
Alliances
3
Als
3
Asia
3
Awards
4
Bioforest
3
Biomidwest
4
Biopharma
4
Bioscience
7
Biotech
7
Biotech-bay
7
Biotech-beach
6
Biotechnology
4
Cancer
7
Ceo
3
Chip
3
Collaboration
4
Commercialization
3
Conference
75
Covid
11
Covid-19
7
Designation
7
Diagnostic
4
Disease
6
Drug
7
Energy
8
Europe
6
Events
13
Fda
7
Financial results
13
Genetown
8
Grant
6
Granted
6
Growth
26
Iot
12
Life science
6
Liver
6
Media
5
Merge
5
Mobile
5
N/a
377
Offering
13
Partnership
4
People
11
Pharm-country
4
Phase 1
6
Phase 2
9
Phase 2b
6
Phase 3
4
Presentation
11
Research
16
Results
31
Sales
5
Security
6
Technology
5
Therapeutics
5
Therapy
8
Treatment
11
Trial
16
Women
6
Entities
Atai life sciences n.v.
1
Biohaven pharmaceutical holding company ltd.
1
Cabot corporation
1
Decibel therapeutics inc
1
Denali therapeutics inc.
1
Eastman chemical company
1
Eloxx pharmaceuticals, inc.
1
Freeline therapeutics holdings plc
1
Itt inc.
1
Marrone bio innovations, inc.
1
Sanofi
1
Soligenix, inc.
1
Ultragenyx pharmaceutical inc.
1
Symbols
ATAI
1
BHVN
1
CBT
1
DBTX
1
DNLI
1
ELOX
1
EMN
1
FRLN
1
ITT
1
MBII
1
RARE
1
SNGX
1
SNY
1
Exchanges
Nasdaq
9
Nyse
2
Crawled Date
2021 - 09 - 09
11
Crawled Time
06:00
1
08:00
1
12:00
3
13:00
1
14:00
1
15:00
1
19:00
1
20:00
1
21:00
1
Source
www.biospace.com
6
www.globenewswire.com
4
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 09 - 09
tags :
Treatment
save search
atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression
Published:
2021-09-09
(Crawled : 21:00)
- globenewswire.com
ATAI
|
$1.875
-4.82%
-5.07%
830K
|
Manufacturing
|
-88.98%
|
O:
1.06%
H:
0.0%
C:
-4.02%
treatment
test
depression
life science
ketamine
Water Treatment Chemicals Market Size to Reach Revenues of USD 38,119.46 Million by 2026 - Arizton
Published:
2021-09-09
(Crawled : 20:00)
- prnewswire.com
ITT
|
$130.48
0.73%
0.0%
380K
|
Producer Manufacturing
|
44.78%
|
O:
0.52%
H:
0.12%
C:
-0.98%
EMN
|
$96.36
-0.46%
0.0%
1.1M
|
Process Industries
|
-11.9%
|
O:
0.71%
H:
1.07%
C:
-0.62%
CBT
|
News
|
$93.4
0.02%
0.0%
180K
|
Process Industries
|
80.14%
|
O:
0.89%
H:
0.0%
C:
-3.27%
treatment
Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North AmericaCompany Also Looks to Expand Footprint in South America with Regulatory Submission of Bionematicide Seed Treatment, MBI-206, in Brazil
Published:
2021-09-09
(Crawled : 19:00)
- biospace.com/
MBII
|
$0.7981
-20.19%
1.49%
|
Process Industries
|
-15.86%
|
O:
2.27%
H:
0.78%
C:
-5.07%
treatment
brazil
submission
drop
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher DiseaseClinical trial site initiation for Gaucher disease Type 1 on track by year end
Published:
2021-09-09
(Crawled : 15:00)
- biospace.com/
FRLN
|
$6.48
0.0%
0
|
Health Technology
|
60.4%
|
O:
0.0%
H:
1.61%
C:
-0.25%
disease
treatment
orphan drug
drug
trial
pons
designation
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS— Investigational EIF2B activator approach has potential to be a first-in-class treatment for ALS —
Published:
2021-09-09
(Crawled : 14:00)
- biospace.com/
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-70.76%
|
O:
-0.11%
H:
2.54%
C:
-0.3%
treatment
phase 1
potential
phase 1b
als
phase 2b
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Published:
2021-09-09
(Crawled : 13:00)
- biospace.com/
DBTX
|
$4.91
-0.81%
-0.2%
0
|
Health Technology
|
-36.4%
|
O:
4.66%
H:
3.72%
C:
-2.85%
disease
treatment
rare pediatric disease designation
orphan drug
drug
hearing loss
designation
rare
Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of Cystic Fibrosis Patients with Nonsense Mutations
Published:
2021-09-09
(Crawled : 12:00)
- globenewswire.com
ELOX
|
$0.825
-51.57%
93K
|
Health Technology
|
-41.73%
|
O:
5.76%
H:
14.29%
C:
4.08%
treatment
fibrosis
fast track
fast track designation
elx-02
designation
cystic fibrosis
Biohaven Spotlights Nurtec® ODT (rimegepant), the only dual-therapy indicated for both the acute and preventive treatment of migraine, at the 2021 International Headache Society - European Headache Federation Joint Congress
Published:
2021-09-09
(Crawled : 12:00)
- biospace.com/
BHVN
|
News
0 d
|
$38.72
-2.25%
-0.28%
970K
|
Health Technology
|
-70.61%
|
O:
-0.14%
H:
2.85%
C:
-0.58%
treatment
europe
migraine
therapy
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Published:
2021-09-09
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.385
-3.75%
-3.9%
490K
|
Health Technology
|
-63.81%
|
O:
12.38%
H:
4.24%
C:
-1.69%
treatment
fda
drug
t-cell
granted
grant
designation
MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy
Published:
2021-09-09
(Crawled : 08:00)
- globenewswire.com
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
-56.72%
|
O:
-0.58%
H:
2.56%
C:
-0.46%
media
treatment
approval
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus
Published:
2021-09-09
(Crawled : 06:00)
- globenewswire.com
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-5.34%
|
O:
-1.54%
H:
0.23%
C:
-0.59%
treatment
phase 3
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.